Free preview
MD Pharmacology NMC syllabus ~5 min read Recent advances last updated on 2026-06-30

Neurosteroids

Neuroactive Steroids as GABA_A-Receptor Positive Allosteric Modulators — Endogenous Allopregnanolone & the Extrasynaptic δ-Subunit Site; Synthetic Agents Brexanolone, Zuranolone, Ganaxolone & Alphaxalone; Physiology, Therapeutics in Depression & Epilepsy, and Limitations

Introduction & definition

  • Neurosteroids (neuroactive steroids) are steroid molecules that rapidly alter neuronal excitability by non-genomic membrane actions — chiefly allosteric modulation of ligand-gated ion channels — rather than the slow genomic action of classical steroid hormones.
  • Terminology — neurosteroid (Baulieu) = steroid synthesised de novo within the nervous system; neuroactive steroid = any steroid (CNS-, peripherally-derived or synthetic) that is pharmacologically active on neuronal targets — used interchangeably in regulatory labelling.
  • Core action — the therapeutically exploited effect is positive allosteric modulation (PAM) of the GABA_A receptor, the principal inhibitory ionotropic receptor of the CNS — the same complex on which benzodiazepines and barbiturates act, but at a pharmacologically distinct steroid-recognition site.
  • Clinical relevance — the first mechanistically novel GABAergic drug class in decades — validated by three FDA approvals (2019–2023) across mood disorders (brexanolone, zuranolone) and epilepsy (ganaxolone).
Continue reading

Neurosteroids

PharmaNotes Pro · LAQ

Sign in with your Google account. If you're already subscribed, the chapter unlocks immediately — otherwise, pick Monthly or Annual on the next step.